The U.S. Food and Drug Administration (FDA) has issued a labeling change requiring the Boxed Warning and other precautions included in prescribing information to be updated for all benzodiazepines. Read more...

The U.S. Food and Drug Administration (FDA) announced that Perrigo Pharmaceutical Company issued a voluntary recall for all unexpired albuterol sulfate inhalation aerosol to the retail level. The September 21, 2020 recall announcement was issued due to the potential clogging of the inhaler, which could result in health risks to patients if they do not receive enough or any medication when using the inhaler. Read more...

An Amerisure claimant needed a new prosthetic leg, so Amerisure reached out to get a quote from the vendor that provided the claimant’s last prosthetic in 2018. Amerisure sent that quote to their partner Optum to verify if the quote was reasonable and the particular prosthetic was clinically appropriate. Read more...

Listed below are brief updates on several recent policy developments across the country. Read more...

The U.S. Food and Drug Administration (FDA) has issued a safety communication regarding the use of hot/cold therapy devices. The September 9, 2020 communication reminds patients and healthcare providers about the importance of following the instructions when providing cold therapy through a water-circulating hot/cold therapy device. Read more...

ODG has been making changes to treatment guidelines. Optum is following suit by changing some of our program parameters. Beginning September 23, 2020, Optum is lowering our opioid alerting parameter to 90 mg of oral morphine equivalents (morphine equivalent dose, or MED) for treating chronic pain. Read more...